Sarcoidosis developing after COVID‐19: A case report

Abstract COVID‐19 has been implicated in the development of a range of autoimmune diseases and medical consequences. Sarcoidosis is an inflammatory disease with sustained granulomatous inflammation. The possible main pathogenesis of sarcoidosis is a dysregulation between immune response and certain...

Full description

Bibliographic Details
Main Authors: Dujrath Somboonviboon, Anan Wattanathum, Narumon Keorochana, Kittisak Wongchansom
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Respirology Case Reports
Subjects:
Online Access:https://doi.org/10.1002/rcr2.1016
_version_ 1811282154843275264
author Dujrath Somboonviboon
Anan Wattanathum
Narumon Keorochana
Kittisak Wongchansom
author_facet Dujrath Somboonviboon
Anan Wattanathum
Narumon Keorochana
Kittisak Wongchansom
author_sort Dujrath Somboonviboon
collection DOAJ
description Abstract COVID‐19 has been implicated in the development of a range of autoimmune diseases and medical consequences. Sarcoidosis is an inflammatory disease with sustained granulomatous inflammation. The possible main pathogenesis of sarcoidosis is a dysregulation between immune response and certain environmental antigens. We present a case of sarcoidosis as an interesting sequela of COVID‐19. The patient was hospitalized due to SARS‐CoV‐2 without complication. Ten weeks after the illness, his chest computed tomography (CT) showed bilateral hilar, paratracheal and subcarinal lymph node enlargement. Endobronchial ultrasound with transbronchial needle aspiration (EBUS‐TBNA) was performed; pathologic findings were that of well‐formed non‐necrotizing granulomas. Complete eye examination reported panuveitis and papillitis in both eyes. On the basis of these findings, sarcoidosis was diagnosed. Therefore, sarcoidosis developing after COVID‐19 was suggested as a possible link between the viral infection and dysregulation of the inflammation process. However, further studies are needed to confirm this association.
first_indexed 2024-04-13T01:46:38Z
format Article
id doaj.art-87338fceae0a47a4b486ca9a00580c28
institution Directory Open Access Journal
issn 2051-3380
language English
last_indexed 2024-04-13T01:46:38Z
publishDate 2022-09-01
publisher Wiley
record_format Article
series Respirology Case Reports
spelling doaj.art-87338fceae0a47a4b486ca9a00580c282022-12-22T03:08:00ZengWileyRespirology Case Reports2051-33802022-09-01109n/an/a10.1002/rcr2.1016Sarcoidosis developing after COVID‐19: A case reportDujrath Somboonviboon0Anan Wattanathum1Narumon Keorochana2Kittisak Wongchansom3Pulmonary and Critical Care Division, Department of Medicine Phramongkutklao Hospital Bangkok ThailandPulmonary and Critical Care Division, Department of Medicine Phramongkutklao Hospital Bangkok ThailandOcular Immunology and Inflammation Division, Department of Ophthalmology Phramongkutklao Hospital Bangkok ThailandDepartment of Pathology Army Institute of Pathology Bangkok ThailandAbstract COVID‐19 has been implicated in the development of a range of autoimmune diseases and medical consequences. Sarcoidosis is an inflammatory disease with sustained granulomatous inflammation. The possible main pathogenesis of sarcoidosis is a dysregulation between immune response and certain environmental antigens. We present a case of sarcoidosis as an interesting sequela of COVID‐19. The patient was hospitalized due to SARS‐CoV‐2 without complication. Ten weeks after the illness, his chest computed tomography (CT) showed bilateral hilar, paratracheal and subcarinal lymph node enlargement. Endobronchial ultrasound with transbronchial needle aspiration (EBUS‐TBNA) was performed; pathologic findings were that of well‐formed non‐necrotizing granulomas. Complete eye examination reported panuveitis and papillitis in both eyes. On the basis of these findings, sarcoidosis was diagnosed. Therefore, sarcoidosis developing after COVID‐19 was suggested as a possible link between the viral infection and dysregulation of the inflammation process. However, further studies are needed to confirm this association.https://doi.org/10.1002/rcr2.1016COVID‐19granulomatoussarcoidosisuveitis
spellingShingle Dujrath Somboonviboon
Anan Wattanathum
Narumon Keorochana
Kittisak Wongchansom
Sarcoidosis developing after COVID‐19: A case report
Respirology Case Reports
COVID‐19
granulomatous
sarcoidosis
uveitis
title Sarcoidosis developing after COVID‐19: A case report
title_full Sarcoidosis developing after COVID‐19: A case report
title_fullStr Sarcoidosis developing after COVID‐19: A case report
title_full_unstemmed Sarcoidosis developing after COVID‐19: A case report
title_short Sarcoidosis developing after COVID‐19: A case report
title_sort sarcoidosis developing after covid 19 a case report
topic COVID‐19
granulomatous
sarcoidosis
uveitis
url https://doi.org/10.1002/rcr2.1016
work_keys_str_mv AT dujrathsomboonviboon sarcoidosisdevelopingaftercovid19acasereport
AT ananwattanathum sarcoidosisdevelopingaftercovid19acasereport
AT narumonkeorochana sarcoidosisdevelopingaftercovid19acasereport
AT kittisakwongchansom sarcoidosisdevelopingaftercovid19acasereport